| Jennifer A Weller, PHD | |
|
570 W Brown Rd, Mesa, AZ 85201-3227 | |
| (480) 344-2002 | |
| (480) 649-0783 |
| Full Name | Jennifer A Weller |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 570 W Brown Rd, Mesa, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417999426 | NPI | - | NPPES |
| 623894 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 3473 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer A Weller, PHD 2929 E Thomas Rd, Phoenix, AZ 85016-8034 Ph: (602) 470-5000 | Jennifer A Weller, PHD 570 W Brown Rd, Mesa, AZ 85201-3227 Ph: (480) 344-2002 |
News Archive
In an effort to help schools reduce the risk of COVID-19 outbreaks as they resume in-person instruction, University of California San Diego and the County of San Diego are testing the Safer at School Early Alert system, an evidence-informed program to detect SARS-CoV-2 at schools and child care centers.
Yadira Alatriste, researcher at the Autonomous Metropolitan University of Mexico designed a remote medical care system that supports the rehabilitation of people with spasticity, an alteration of the nervous system related to increased tone muscle making motor skills difficult or impossible for those affected.
Sinapis Pharma, Inc. has successfully completed a Bridge financing to continue to support its drug development program. Sinapis Pharma has discovered and is developing a novel therapeutic approach to neuronal protection using its intravenous methamphetamine technology. The company has strong pre-clinical data in stroke and traumatic brain injury animal models conclusively demonstrating a 12-hour therapeutic window and multiple pathway neuroprotection.
A new actuarial study released by The Pharmaceutical Care Management Association examining the impact proposed changes to the Medicare prescription drug program finds that eliminating preferred pharmacy networks in Part D would increase premiums by approximately $63 annually for over 75 percent of Part D enrollees and raise overall program costs by an estimated $24 billion over the next ten years.
› Verified 3 days ago
Amol Rohit Patel, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 570 W Brown Rd, Mesa, AZ 85201 Phone: 480-344-2028 | |
Dr. Kate Gillpatrick, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 570 W Brown Rd, Mesa, AZ 85201 Phone: 480-344-2000 | |
Nancy L Vander Veer, PSYD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 570 W Brown Rd, Mesa, AZ 85201 Phone: 602-344-2002 Fax: 480-649-0783 | |
Dr. Yaniv Simon, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 570 W Brown Rd, Mesa, AZ 85201 Phone: 480-344-2026 Fax: 480-344-0219 | |
Dr. Samuel Hutchinson, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 4135 S Power Rd, Mesa, AZ 85212 Phone: 480-397-2830 | |
Payam M Sadr, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 570 W Brown Rd, Mesa, AZ 85201 Phone: 480-344-2000 Fax: 480-649-0783 | |
Troy Michael Fulton, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3707 E Southern Ave, Mesa, AZ 85206 Phone: 480-509-7738 |